“Adding those clinically proven intraocular dyes to our already comprehensive surgical portfolio will help surgeons improve visibility of specific eye tissues, as well as identify the clear layers of the eye during vitreoretinal, corneal and cataract surgery,” said Joe Gordon, global president. Consumer, Vision Care and Surgical, Bausch Lomb. ” Our exclusive collaboration with Alfa Instruments demonstrates our commitment to providing eye care professionals with cutting-edge products designed to help them achieve the most productive surgical outcomes imaginable for their patients. “
The only common thread of Vitreocare intraocular dyes is lutein, a clear of light blue herbs. Research has shown that lutein is a safe and effective coloring agent, and its antioxidant properties can further protect the retina in eye surgery. 1-6 In addition, Single Lutein Blue and Double Lutein Blue are formulated with the new pure benzyl-Brilliant Blue (PBB®) molecule of maximum purity (> 99%). , to avoid possible cytotoxicity in non-target tissues. 7
“We are revered and excited to marry Bausch Lomb, one of the world’s best-known and most reputable eye care companies, as it will expand access to our intraocular dyes through Bausch Lomb’s extensive distribution network,” said Fabio David, CEO of Alfa. Instruments. ” We look forward to running in combination to help the visual desires of patients undergoing vitreoretinal, cataract or corneal surgery. “
Alfa Instruments surgical dyes have lately been CE marked and sold in the EU, the UK and Switzerland. Bausch Lomb plans to start the distribution of intraocular dyes in all EU countries, Italy, in the first part of 2023. Bausch Lomb and Alfa Instruments are also exploring regulatory needs and approvals for dye surgery in other markets.
For more information about VitreoCare, www. vitreocare. com.
Bausch Lomb is committed to protecting and enhancing the gift of sight for millions of people around the world, from the moment of birth to each and every standard of living. Its comprehensive portfolio of more than 400 products includes touch lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products, and ophthalmic surgical devices and instruments. Founded in 1853, Bausch Lomb has a significant global presence in studies and development, production and sales with more than 12,000 employees and a presence in nearly one hundred countries. Bausch Lomb is headquartered in Vaughan, Ontario, with offices in Bridgewater, New Jersey. For more information, visit www. bausch. com and connect with us on Twitter, LinkedIn, Facebook and Instagram.
This press release may include forward-looking statements, which may sometimes be made known by the use of the words “anticipates”, “expects”, “expects”, “intends”, “expects”, “should”, “may also simply ‘ , ‘would’, ‘possibly’, ‘believes’, ‘estimates’, ‘prospective’, ‘target’ or ‘continues’ and diversifications or similar expressions These statements are based on management’s existing expectations and ideals and are subject of certain dangers and uncertainties that may also cause actual effects to differ slightly from those described in the forward-looking statements. These dangers and uncertainties include, but are not limited to, the dangers and uncertainties discussed in Bausch + Lomb’s filings with the United States. The United States Securities and Exchange Commission and the Canadian Securities Administrators, the points of which are incorporated by reference, also include, but are not limited to, the dangers and uncertainties caused through or similar to the evolution of the C The OVID-19 pandemic, as well as the concern of this pandemic and its possible effects, adding that the severity, duration and long-term effect are highly uncertain and they cannot be predicted, and that they can also have a moderate adverse effect. an effect on Bausch + Lomb, adding, but not limited to, delays in the progression of their projects, releases, and prices (possibly increasing). Readers are cautioned not to place undue reliance on any such forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch + Lomb assumes no legal responsibility to update any such forward-looking statements to reflect events or events after the date of this press release or to reflect actual effects, except as required by law.
PBB Pure Benzyl-Brilliant Blue is a registered trademark of Alfa Instruments. All other product/brand names are registered by their respective owners. © 2022 Bausch
View content to download media: https://www. prnewswire. com/news-releases/bausch–lomb-named-exclusive-global-distributor-of-alfa-instruments-srl-intraocular-dyes-301615977. html
SOURCEBausch Lomb Corporation